This event will feature live presentations from life sciences executives addressing various investment opportunities in Biopharma, Biotech, Medtech and Infant Nutrition.

 

Co-Host

Zacks SCR Logo

 

Thursday, June 23rd Agenda
 
9:30 AM ET
Orexo AB

OTCQX: ORXOY | Nasdaq STO: ORX
Industry: Substance Use Disorder Pharmaceuticals and Digital Therapies
Nikolaj Sørensen, President and CEO

10:00 AM ET
Else Nutrition

OTCQX: BABYF | TSX: BABY
Industry: Plant-Based Nutrition
Hamutal Yitzhak, Co-Founder and CEO

10:30 AM ET
Izotropic Corporation

OTCQB: IZOZF | CSE: IZO
Industry: 3D Breast Cancer Imaging Technology
Dr. John McGraw, CEO

11:00 AM ET
Alterity Therapeutics

NASDAQ: ATHE | ASX: ATH
Industry: Disease Therapy - Neurodegenerative
David Stamler, M.D., CEO

11:30 AM ET
Satellos Bioscience

Pink: MSCLF | TSX-V: MSCL
Industry: Biotech - Skeletal Muscle Regeneration
Frank Gleeson, Founder & CEO

12:00 PM ET
Alpha Cognition Inc.

OTCQB: ACOGF | TSX-V: ACOG
Industry: Biopharma - Neurodegenerative
Michael McFadden, CEO

12:30 PM ET
Emmaus Life Sciences, Inc.

OTCQX: EMMA
Industry: Biopharma - Sickle Cell Disease
Yutaka Niihara, Chief Executive Officer, Chairman of the Board

1:00 PM ET
Reviva Pharmaceuticals

NASDAQ: RVPH
Industry: Biopharma - CNS, Respiratory and Metabolic Diseases
Laxminarayan Bhat, PhD, Founder, CEO and President
John D. Vandermosten, CFA, Zacks Senior Biotech Analyst

1:30 PM ET
Poolbeg Pharma PLC

OTCQB: POLBF | AIM: POLB
Industry: Biopharma - Infectious Diseases
Cathal Friel, Chairman
Jeremy Skillington, CEO

2:00 PM ET
Celsion Corporation

Nasdaq: CLSN
Industry: Biotech - Cancer Research
Khursheed Anwer, EVP & Chief Science Officer
Jeffrey Church, SVP & CFO

{"@context": "https://schema.org","@type": "Event","name": "Life Sciences Investor Forum","startDate": "2022-06-23T09:00:00-04:00","eventAttendanceMode": "OnlineEventAttendanceMode","location":{"@type": "VirtualLocation","url": "https://vic-lifesci-jun22.hubb.me"},"description": "Virtual Investor Conferences combine leading-edge online conferencing and investor communications capabilities with a comprehensive global investor audience network"}